Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors

Theranostics

Volumn 2, Issue 10, 2012, Pages 976-987

  Lukianova Hleb, Ekaterina Y ^a   Ren, Xiaoyang ^b   Townley, Debra ^c   Wu, Xiangwei ^b   Kupferman, Michael E ^b   Lapotko, Dmitri O ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer cell; Plasmonic nanobubble

Indexed keywords

CETUXIMAB; DOXORUBICIN; GOLD NANOPARTICLE; NANOBUBBLE; NANOSPHERE; PLASMONIC NANOBUBBLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONJUGATE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFICACY; DRUG SENSITIVITY; ENDOCYTOSIS; ENDOSOME; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; MULTIDRUG RESISTANCE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84870569945     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.5116     Document Type: Article

References (63)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA: Cancer J Clin. 2009;60:277-300.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer J Clin. 2011;61:69-90.
3. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310-6.
4. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as An emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60.
5. Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol. 2010;5:465-72.
6. Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011;149:65-71.
7. Braun GB, Pallaoro A, Wu G, Missirlis D, Zasadzinski JA, Tirrell M, et al. Laser-activated gene silencing via gold nanoshell-siRNA conjugates. ACS Nano. 2009;3:2007-15.
8. Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphoni-um-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release. 2012;159:393-402.
9. Woo HN, Chung HK, Ju EJ, Jung J, Kang HW, Lee SW, et al. Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparti-cle for cancer therapy. Int J Nanomedicine. 2012;7:2197-208.
10. Koning GA, Eggermont AM, Lindner LH, Ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res. 2010;27:1750-4.
11. Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV. Remote trig-gered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano. 2011;5:4919-26.
12. Park JH, von Maltzahn G, Ong LL, Centrone A, Hatton TA, Ruoslahti E, et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater. 2010;22:880-5.
13. Stathopoulos GP, Antoniou D, Dimitroulis J, Michalopoulou P, Bastas A, Marosis K, et al. Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Ann Oncol. 2010;21:2227-32.
14. Zhang F, Zhu L, Liu G, Hida N, Lu G, Eden HS, et al. Multimodality imaging of tumor response to Doxil. Theranostics. 2011;1:302-9.
15. Kost J, Leong K, Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A 1989;86:7663-6.
16. McCarthy MJ, Soong DS, Edelman ER. Control of drug release from polymer matrices impregnated with magnetic beads - a proposed mechanism and model for enhanced release. J Control Release. 1984;1:143-7.
17. Husseini GA, Pitt WG. The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol 2008;8:2205-15.
18. Rapoport N. Ultrasound-mediated micellar drug delivery. Int J Hyper-thermia. 2012;28: 374-85.
19. Shukla R, Chanda N, Zambre A, Upendran A, Katti K, Kulkarni RR, et al. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci U S A 2012;109:12426-31.
20. Yuan H, Fales AM, Vo-Dinh T. TAT peptide-functionalized gold nanos-tars: enhanced intracellular delivery and efficient nir photothermal therapy using ultralow irradiance. J Am Chem Soc. 2012;134:11358-61.
21. Huang HC, Yang Y, Nanda A, Koria P, Rege K. Synergistic administra-tion of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices. Nanomedicine 2011;6:459-73.
22. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J. 2003;84:4023-32.
23. Cherukuri P, Glazer ES, Curley SA. Targeted hyperthermia using metal nanoparticles. Adv Drug Deliver Rev. 2010;62:339-45.
24. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond). 2007;2:125-32.
25. Dickerson EB, Dreaden EC, Huang X, El-Sayed I, Chu H, Pushpanketh S, at el. gold nanorod assisted near-infrared plasmonic photothermal ther-apy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008;269:57-66.
26. Gilstrap K, Hu X, Lu X, He X. Nanotechnology for energy-based cancer therapies. Am J Cancer Res. 2011;1:508-20.
27. Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G. Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, func-tional nanocarriers. ACS Nano. 2011;5:1995-2003.
28. Li Z, Huang P, Zhang X, Lin J, Yang S, Liu B, et al. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm. 2010;7:94-104.
29. Gobin AM, O'Neal DP, Watkins DM, Halas NJ, Drezek RA, West JL. Near infrared laser-tissue welding using nanoshells as an exogenous absorber. Lasers Surg Med. 2005;37:123-9.
30. Gormley AJ, Larson N, Sadekar S, Robinson R, Ray A, Ghandehari H. Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today. 2012;7:158-67.
31. Jang B, Park JY, Tung CH, Kim IH, Choi Y. Gold nano-rod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano. 2011;5:1086-94.
32. Záruba K, Králová J, Rezanka P, Poucková P, Veverková L, Král V. Modified porphyrin-brucine conjugated to gold nanoparticles and their application in photodynamic therapy. Org Biomol Chem 2010;8:3202-6.
33. Cheng Y, Meyers JD, Broome A-M, Kenney ME, Basilion JP, Burda C. Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc. 2011;133:2583-91.
34. Prentice P, Cuschierp A, Dholakia K, Prausnitz M, Campbell P. Mem-brane disruption by optically controlled microbubble cavitation. Nat Phys 2005;1:107-10.
35. Liu HL, Chen WS, Chen JS, Shih TC, Chen YY, Lin WL. Cavita-tion-enhanced ultrasound thermal therapy by combined low- and high-frequency ultrasound exposure. Ultrasound Med Biol. 2006;32:759-67.
36. Arita Y, Torres-Mapa ML, Lee WM, Cizmar T, Campbell P, Gunn-Moore FJ, et al. Spatially optimized gene transfection by laser-induced breakdown of optically trapped nanoparticles. Appl Phys Lett. 2011;98:093702.
37. Lukianova-Hleb E, Wagner D, Brenner M, Lapotko D. Cell-specific transmembrane injection of molecular cargo with gold nanoparti-cle-generated transient plasmonic nanobubbles. Biomaterials. 2012;33:5441-50.
38. Lukianova-Hleb EY, Ren X, Zasadzinski JA, Wu X, Lapotko D. Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells. Adv Mater. 2012;24:3831-7.
39. Wagner DS, Delk NA, Lukianova-Hleb EY, Hafner JH, Farach-Carson MC, Lapotko DO. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials. 2010;31:7567-74.
40. Lukianova-Hleb E, Belyanin A, Kashinath S, Wu X, Lapotko D. Plas-monic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells. Biomaterials. 2012;33:1821-6.
41. Lukianova-Hleb EY, Lapotko DO. Influence of transient environmental photothermal effects on optical scattering by gold nanoparticles. Nano Lett. 2009;9:2160-6.
42. Lapotko DO, Lukianova EY, Oraevsky AA. Selective laser nano-thermolysis of human leukemia cells with microbubbles generated around clusters of gold nanoparticles. Lasers Surg Med. 2006;38:631-42.
43. Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, et al. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 2003;63:3154-61.
44. Herbst RS, Langer CJ. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol. 2002;29:27-36.
45. Yokoyama T, Tam J, Kuroda S, Scott AW, Aaron J, Larson T, et al. EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLosOne. 2011;6:e25507.
46. Centocor Ortho Biotech Products. Doxil: Product Information Book. USA: Centocor Ortho Biotech Products. 2011.
47. Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, Yu D, et al. KiSS1 medi-ates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Oncogene. 2011;30:3163-73.
48. Hleb E, Hafner JH, Myers JN, Hanna EY, Rostro BC, Zhdanok SA, et al. LANTCET: elimination of solid tumor cells with photothermal bubbles generated around clusters of gold nanoparticles. Nanomedicine (Lond). 2008;3:647-67.
49. Lapotko DO, Lukianova-Hleb EY, Oraevsky AA. Clusterization of nanoparticles during their interaction with living cells. Nanomedicine (Lond). 2007;2:241-53.
50. Welch AJ, van Gemert MJC. Optical-thermal response of laser-irradiated tissue, 2nd Ed. Springer, 2011.
51. McDannold NJ, Vykhodtseva NI, Hynynen K. Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits. Radiology. 2006;241:95-106.
52. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321-7.
53. Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release. 2009;138:268-76.
54. Ferrara KW. Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev. 2008;60:1097-102.
55. Wang CH, Huang YF, Yeh CK. Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging. Langmuir. 2011;27:6971-6.
56. Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895-904.
57. Cavalli R, Bisazza A, Trotta M, Argenziano M, Civra A, et al. New chi-tosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization. Int J Nanomedicine. 2012;7:3309-18.
58. Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA. Doxoru-bicin and Paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm. 2011;414:161-70.
59. Zhang HF, Maslov K, Stoica G, Wang LV. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat Biotechnol. 2006;24:848-51.
60. Conjusteau A, Ermilov S, Lapotko D, Liao H, Hafner J, Eghtedari M, et al. Metallic nanoparticles as optoacoustic contrast agents for medical im-aging. Proc SPIE. 2006;6086:155-65.
61. Laser Institute of America. American National Standard For Safe Use Of Lasers (ANSI Z136.1-2007). Laser Institute of America. 2007.
62. Lukianova-Hleb EY, Ren X, Constantinou P, Danysh B, Shenefelt D, Carson D, et al. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLos One. 2012;7:e34537.
63. Lukianova-Hleb EY, Oginsky AO, Samaniego AP, Shenefelt DL, Wagner DS, Hafner JH, et al. Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics 2011;1:3-17.